Assembly Biosciences, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Assembly Biosciences, Inc. (ASMB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.56 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 11.36M shares, a 429.01% increase year-over-year.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.15M shares, a 88.75% increase year-over-year.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 1.14M shares, a 10.79% increase year-over-year.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 1.03M shares, a 88.79% decline year-over-year.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.01M shares, a 500.63% increase from fiscal 2024.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.83M shares, a 88.68% increase from fiscal 2023.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 971.82K shares, a 7.39% increase from fiscal 2022.
- Assembly Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 904.93K shares, a 87.45% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 11.56M shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 11.36M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 11.01M shares 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | 11.05M shares 10-Q · filed 2025-11-10 | |||||||
| 2025-06-30 | 2.36M shares 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | 2.15M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 1.83M shares 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | 1.83M shares 10-Q · filed 2025-11-10 | |||||||
| 2024-06-30 | 1.90M shares 10-Q · filed 2025-08-06 | |||||||
| 2024-03-31 | 1.14M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 971.82K shares 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | 926.24K shares 10-Q · filed 2024-11-07 | 11.11M shares 10-Q · filed 2023-11-08 | ||||||
| 2023-06-30 | 966.70K shares 10-Q · filed 2024-08-08 | 11.60M shares 10-Q · filed 2023-08-09 | ||||||
| 2023-03-31 | 1.03M shares 10-Q · filed 2024-05-08 | 12.33M shares 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | 904.93K shares 10-K · filed 2024-03-28 | 10.86M shares 10-K · filed 2023-03-22 | ||||||
| 2022-09-30 | 11.38M shares 10-Q · filed 2023-11-08 | |||||||
| 2022-06-30 | 8.98M shares 10-Q · filed 2023-08-09 | |||||||
| 2022-03-31 | 9.16M shares 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | 7.21M shares 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | 7.35M shares 10-Q · filed 2022-11-08 | |||||||
| 2021-06-30 | 7.19M shares 10-Q · filed 2021-08-05 | 7.19M shares 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | 8.09M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 7.49M shares 10-K · filed 2022-03-11 | |||||||
| 2020-09-30 | 7.54M shares 10-Q · filed 2021-11-04 | |||||||
| 2020-06-30 | 3.59M shares 10-Q · filed 2021-08-05 | 7.66M shares 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | 7.42M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 6.27M shares 10-K · filed 2021-02-25 | |||||||
| 2019-09-30 | 6.16M shares 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | 5.72M shares 10-Q · filed 2020-08-05 | 5.72M shares 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | 5.76M shares 10-Q · filed 2020-05-08 | 5.73M shares 10-Q · filed 2019-05-09 | ||||||
| 2018-12-31 | 5.24M shares 10-K · filed 2021-02-25 | |||||||
| 2018-09-30 | 4.79M shares 10-Q · filed 2019-11-07 | 4.78M shares 10-Q · filed 2018-11-08 | ||||||
| 2018-06-30 | 5.11M shares 10-Q · filed 2019-08-05 | 4.95M shares 10-Q · filed 2018-08-08 | ||||||
| 2018-03-31 | 5.09M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 4.69M shares 10-K · filed 2020-03-04 | |||||||
| 2017-09-30 | 4.88M shares 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | 4.85M shares 10-Q · filed 2018-08-08 | |||||||
| 2017-03-31 | 4.83M shares 10-Q · filed 2018-05-07 | |||||||
| 2016-12-31 | 4.47M shares 10-K · filed 2019-02-28 | |||||||
| 2016-09-30 | 4.39M shares 10-Q · filed 2017-11-01 | |||||||
| 2016-06-30 | 4.11M shares 10-Q · filed 2017-08-09 | |||||||
| 2016-03-31 | 3.87M shares 10-Q · filed 2017-05-08 | |||||||
| 2015-12-31 | 3.38M shares 10-K · filed 2018-03-08 | |||||||
| 2015-09-30 | 3.30M shares 10-Q · filed 2016-11-09 | |||||||
| 2015-06-30 | 3.23M shares 10-Q · filed 2016-08-09 | |||||||
| 2015-03-31 | 3.23M shares 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | 3.52M shares 10-K · filed 2017-03-02 | |||||||
| 2014-09-30 | 3.47M shares 10-Q · filed 2015-11-09 | |||||||
| 2014-06-30 | 3.81M shares 10-Q · filed 2014-08-14 | 762.83K shares 10-Q · filed 2015-08-13 | 3.81M shares 10-Q · filed 2014-08-14 | |||||
| 2014-03-31 | 762.83K shares 10-Q · filed 2015-05-08 | 3.81M shares 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | 758.91K shares 10-K · filed 2015-03-16 | 3.57M shares 10-K · filed 2014-03-31 | ||||||
| 2013-09-30 | 5.59M shares 10-Q · filed 2013-11-12 | |||||||
| 2013-06-30 | 4.98M shares 10-Q · filed 2014-08-14 | 5.52M shares 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | 4.98M shares 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | 2.75M shares 10-K · filed 2014-03-31 | 2.76M shares 10-K · filed 2013-03-18 | ||||||
| 2012-09-30 | 3.13M shares 10-Q · filed 2013-11-12 | |||||||
| 2012-06-30 | 3.15M shares 10-Q · filed 2013-08-09 | |||||||
| 2012-03-31 | 3.17M shares 10-Q · filed 2013-05-10 | |||||||
| 2011-12-31 | 3.00M shares 10-K · filed 2013-03-18 | |||||||
| 2011-09-30 | 2.92M shares 10-Q · filed 2012-11-13 | |||||||
| 2011-06-30 | 2.92M shares 10-Q · filed 2012-08-09 | |||||||
| 2010-12-31 | 2.09M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |